About Westpfalz-Klinikum GmbH
Die Westpfalz-Klinikum GmbH ist eine Trägergesellschaft für die Kliniken in Kaiserslautern, Kirchheimbolanden, Kusel, Rockenhausen und weitere Tochterfirmen mit Sitz in Kaiserslautern.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
9
Biotronik SE & Co. KG
3
European Organisation for Research and Treatment of Cancer - EORTC
2
GWT-TUD GmbH
2
Technische Universität Dresden
2
Allergan
1
German High-Grade Non-Hodgkin's Lymphoma Study Group
1
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
1
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
1
Heidelberg University
1
IHF GmbH - Institut für Herzinfarktforschung
1
Clinical Trials at Westpfalz-Klinikum GmbH
During the past decade, Westpfalz-Klinikum GmbH conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on
average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
2002-05-01
Unknown status
220
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
2003-05-01
Completed
86
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Westpfalz-Klinikum GmbH" #1 sponsor was "German CLL Study Group" with 9 trials, followed by "Biotronik SE & Co. KG" with 3 trials
sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored, "GWT-TUD GmbH" with 2 trials sponsored and "Technische Universität Dresden"
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Westpfalz-Klinikum GmbH"
#1 collaborator was "Bayer" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Nordic CLL Study Group (NCLLSG)" with 2 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were
collaborators in the rest 32 trials.
Clinical Trials Conditions at Westpfalz-Klinikum GmbH
According to Clinical.Site data, the most researched conditions in "Westpfalz-Klinikum GmbH" are
"Chronic Lymphocytic Leukemia" (8 trials), "Heart Failure" (4 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Leukemia" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Westpfalz-Klinikum GmbH" in a lesser frequency.
Clinical Trials Intervention Types at Westpfalz-Klinikum GmbH
Most popular intervention types in "Westpfalz-Klinikum GmbH" are "Drug" (20 trials), "Biological" (11 trials), "Procedure" (6 trials), "Device" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "Fludarabine" (5 trials), "Rituximab" (4 trials), "cyclophosphamide" (3 trials), "peripheral blood stem cell transplantation" (3 trials) and "radiation therapy" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Westpfalz-Klinikum GmbH
The vast majority of trials in "Westpfalz-Klinikum GmbH" are
34 trials for "All" genders.
Clinical Trials Status at Westpfalz-Klinikum GmbH
Currently, there are NaN active trials in "Westpfalz-Klinikum GmbH".
1 are not yet recruiting,
5 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Westpfalz-Klinikum GmbH,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Westpfalz-Klinikum GmbH, 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 4 trials that are defined as “Not Applicable".
Departments of Westpfalz-Klinikum GmbH
Westpfalz-Klinikum GmbH has several departments that took part in Clinical trials: "Westpfalz-Klinikum, Klinik für Innere Medizin I" - 2 trials
Departments List
Name
City
Trials